Journal Mobile Options
Table of Contents
Vol. 35, No. 2-3, 2002
Issue release date: March–June 2002
Psychopathology 2002;35:176–180

French Classification for Child and Adolescent Mental Disorders

Mises R. · Quemada N. · Botbol M. · Burzsteijn C. · Garrabe J. · Golse B. · Jeammet P. · Plantade A. · Portelli C. · Thevenot J.P.
Fédération Française de Psychiatrie (FFP), Paris, France

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


This report presents the French Classification of Child and Adolescent Mental Disorders (CFTMEA), operational since 1983 and validated through a broad multicentric study. CFTMEA is now the classification of reference for French child psychiatrists, who appear to be comfortable with it because it fits their diagnostic and therapeutic work. It bases its clinical categories on a psychopathological approach which includes an appraisal of potentials and prognosis. CFTMEA is deliberately built on two quite distinct axes: Axis I: basic clinical categories, and Axis II: associated and possibly etiological factors. The CFTMEA favors a broad appraisal of the disorders that it classifies, seeking whenever possible to establish a structural diagnosis based on psychodynamic psychopathology. The CFTMEA does not claim to be atheoretical, but does not impose a theoretical allegiance, because it is compatible with any etiological concepts. The CFTMEA’s last revision (R 2000) is in an advanced phase of validation.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Mises R: Classification française des troubles mentaux de l’enfant et de l’adolescent, Paris, 2–4 juin 1989. Neuropsychiatr Enfance 1990;38:521–597.
  2. Mises RJ, Fortineau P, Jeammet JL, Lang P, Mazet A, Plantade N, Quemada N: Classification française des troubles mentaux de l’enfant et de l’adolescent. Psychiatr Enfant 1988;31:67–134.

    External Resources

  3. Mises RN, Quemada N: Déficience mentale et processus: Quelques repères épidémiologiques et cliniques. Neuropsychiatr Enfance 1993;41:571–574.
  4. Mises R, Quemada N: Classification des handicaps en pathologie mentale de l’enfant et de l’adolescent. Incapacités, désavantages et retentissement sur la qualité de vie familiale. Inform Psychiatr 1994;70–75:453–462.
  5. Mises RN, Quemada N: Classifications françaises des troubles mentaux et des handicaps chez l’enfant et l’adolescent. Psychiatr Fr 1995;1:78–87.
  6. Mises R, Quemada N: Classifications françaises des troubles mentaux des handicaps en psychiatrie de l’enfant et de l’adolescent. Pour Rech 2000;24:8.
  7. Portelli C, Frydman F, Mises R: JPSY: Système expert de la classification française des troubles mentaux de l’enfant et de l’adolescent. Neuropsychiatr Enfance 1990;38:617–625.
  8. Portelli C, Frydmann F, Mises R: JPSY, un système expert d’aide au diagnostic. Inspiré par la classification française des troubles mentaux de l’enfant et de l’adolescent. Inform Psychiatr 1992;68:947–954.
  9. Quemada N, Casadebaig F: Caractéristiques cliniques d’une clientèle de secteurs psychiatriques publics. Evol Psychiatr 1992;57:201–211.
  10. Thevenot JP, Quemada N: Les nouveaux consultants dans 13 secteurs de psychiatrie infantile. Etude épidémiologique. Inform Psychiatr 1991;67:558–564.
  11. Thevenot JP, Quemada N: Enquête sur les demandes d’hospitalisation à temps complet en psychiatrie infanto-juvénile en Ile-de-France. Premiers résultats globaux. Inform Psychiatr 1993;69:353–358.
  12. Thevenot JP, Quemada N: Les difficultés de l’accès aux soins institutionnels: Une enquête épidémiologique en Ile-de-France. Enfances Psy 1999;7:58–63.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50